Probiotic, prebiotic, and synbiotic use in critically ill patients

Current Opinion in Critical Care

Volumn 18, Issue 2, 2012, Pages 186-191

  Morrow, Lee E ^a,b   Gogineni, Vijaya ^b   Malesker, Mark A ^c  

^a Nebraska and Western Iowa Veterans' Affairs Hospital   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY   (United States)

Author keywords

critical care; nosocomial infection; prebiotics; probiotics; synbiotics

Indexed keywords

PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ACUTE PANCREATITIS; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC RESISTANCE; CLOSTRIDIUM DIFFICILE INFECTION; CRITICAL ILLNESS; DIARRHEA; DRUG MECHANISM; DRUG SAFETY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PROPHYLAXIS; REVIEW; SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DIARRHEA; DRUG RESISTANCE, MICROBIAL; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; PANCREATITIS; PNEUMONIA, VENTILATOR-ASSOCIATED; PREBIOTICS; PROBIOTICS; SYNBIOTICS; TREATMENT OUTCOME;

EID: 84858792680     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283514b17     Document Type: Review

References (44)

1. De Vrese M, Schrezenmeir J. Probiotics, prebiotics, synbiotics. Adv Biochem Eng Biotechnol 2008; 111:1-66.
2. Mack DR, Ahrne S, Hyde L, et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003; 52:827-833. (Pubitemid 36613489)
3. Mattar AF, Teitelbaum DH, Drongowski RA, et al. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 2002; 18:586-590. (Pubitemid 36069911)
4. Kelsall BL. Innate and adaptive mechanisms to control pathological intestinal inflammation. J Pathol 2008; 214:242-259. (Pubitemid 351160161)
5. Mondel M, Schroeder BO, Zimmermann K, et al. Probiotic E. coli treatment mediates antimicrobial human b-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2008; 2:166-172.
6. Schlee M, Harder J, Koten B, et al. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 2008; 151:528-535. (Pubitemid 351160737)
7. Schauber J, Svanholm C, Termen S, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signaling pathways. Gut 2003; 52:735-741. (Pubitemid 36528878)
8. Ogawa M, Shimizu K, Nomoto K, et al. Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int J Food Microbiol 2001; 68:135-140. (Pubitemid 32703733)
9. Lievin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006; 19:315-337.
10. Duquesne S, Petit V, Peduzzi J, Rebuffat S. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria. J Mol Microbiol Biotechnol 2007; 13:200-209. (Pubitemid 47378149)
11. Flynn S, van Sinderen D, Thornton GM, et al. Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology 2002; 148:973-984. (Pubitemid 34436774)
12. Rea MC, Clayton E, O'Connor PM, et al. Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains. J Med Microbiol 2007; 56:940-946. (Pubitemid 47047488)
13. Sherman PM, Johnson-Henry KC, Yeung HP, et al. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 2005; 73:5183-5188. (Pubitemid 41105678)
14. Altenhoefer A, Oswald S, Sonnenborn U, et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 2004; 40:223-229. (Pubitemid 38368186)
15. Lammers KM, Helwig U, Swennen E, et al. Effect of probiotic strains on interleukin-8 production by HT29/19A cells. Am J Gastroenterol 2002; 97:1182-1186. (Pubitemid 34478119)
16. Otte JM, Podolsky DK. Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004; 286:G613-G626. (Pubitemid 38374981)
17. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289:1560-1563.
18. Kabeerdoss J, Shobana DR, Regina MR, et al. Effect of yoghurt containing Bifidobacterium lactis Bb 12(R) on faecal excretion of secretory immunoglobulin A and human beta-defensin-2 in healthy adult volunteers. Nutr J 2011; 10:138.
19. Wen K, Li G, Bui T, et al. High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 2012; 30:1198-1207.
20. Meuller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006; 72:1027-1033. (Pubitemid 43271206)
21. Guigoz Y, Dore J, Schiffrin EJ. The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 2008; 11:13-20. (Pubitemid 350295220)
22. McFarland LV. Systemic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010; 16:2202-2222.
23. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:e64.
24. Szajewska H, Mrukowicz J. Meta-analysis: nonpathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Aliment Pharmacol Ther 2005; 22:365-372. (Pubitemid 41248102)
25. Castagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 1996; 64:5225-5232. (Pubitemid 26403985)
26. Qamar A, Aboudola S, Warny M, et al. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 2001; 69:2762-2765. (Pubitemid 32239759)
27. Siempos II, Ntaidou TK, Falagas M. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010; 38:954-962.
28. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182:1058-1064.
29. Zhang DW, Du P, Gao J, et al. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am J Med Sci 2011 [Epub ahead of print].
30. Tan M, Zhu JC, Zhang LM, Yin HH. Effects of probiotics on serum levels of Th1/Th2-cytokines and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care 2011 15 [Epub ahead of print].
31. Eguchi S, Takatsuki M, Hidaka M, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg 2011; 201:498-502.
32. Spindler-Vesel A, Bengmark S, Vovk I, et al. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 2007; 31:119-126.
33. McGee RG, Bakens A, Wiley K, et al. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2011; 11:CD008716.
34. Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33:662-671.
35. Akyol S, Mas MR, Comert B, et al. The effect of antibiotic and probiotic combination therapy on secondary pancreatic infections and oxidative stress parameters in experimental acute necrotizing pancreatitis. Pancreas 2003; 26:363-367. (Pubitemid 36529962)
36. Muftuoglu MA, Isikgor S, Tosun S, Saglam A. Effects of probiotics on the severity of experimental acute pancreatitis. Eur J Clin Nutr 2006; 60:464-468.
37. Van Minnen LP, Timmerman HM, Lutgendorff F, et al. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 2007; 141:470-480. (Pubitemid 46441310)
38. Oláh A, Belágyi T, Issekutz A, et al. Randomized clinical trial of specific lactobacillus and fiber supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89:1103-1107. (Pubitemid 34989215)
39. Qin HL, Zheng JJ, Tong DN, et al. Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur J Clin Nutr 2008; 62:923-930.
40. Oláh A, Belágyi T, Pótó L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology 2007; 54:590-594. (Pubitemid 46724735)
41. Li YM. Adjuvant therapy for probiotics in patients with severe acute pancreatitis: an analysis of 14 cases. Shijie Huaren Xiaohua Zazhi 2007; 15:302-304.
42. Karakan T, Ergun M, Dogan I, et al. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study. World J Gastroenterol 2007; 13:2733-2737. (Pubitemid 46964279)
43. Wu XG, Zhang QC. Adjuvant therapy for probiotics in patients with severe acute pancreatitis with hepatic lesion: an analysis of 27 cases. Clin Med 2009; 29:51-52.
44. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebocontrolled trial. Lancet 2008; 371:651-659.